USD10
RCUS Shares
About Arcus BiosciencesArcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
USD10
RCUS Shares
About Arcus BiosciencesArcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$2.89B
OPEN PRICE
$21.95
LOW (1Y)
$6.50
HIGH (1Y)
$26.40
LOW (24H)
$21.52
HIGH (24H)
$23.45
VOLUME (24H)
$1.58M
6.6%
Price history
Time | Price | Change |
|---|---|---|
Today | $21.95 | |
1 Day | $22.96 | |
1 Week | $20.80 | |
1 Month | $22.21 | |
1 Year | $7.26 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
